发明名称 Pyrano[3,2-c]pyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them.
摘要 <p>A compound of formula (I) or a pharmaceutically acceptable salt thereof:&lt;!-- EPO &lt;DP n="2"&gt; --&gt;&lt;Chemistry id="chema01" num="0001"&gt;&lt;Image id="ia01" he="52" wi="99" file="IMGA0001.TIF" imgContent="chem" imgFormat="TIFF" inline="no" /&gt;&lt;/Chemistry&gt;wherein: &lt;UnorderedLists id="ula01" listStyle="none"&gt;&lt;ListItem&gt;one of R, and F&lt;Sub&gt;2&lt;/Sub&gt; is hydrogen or C&lt;Sub&gt;1-4&lt;/Sub&gt; alkyl and the other is C&lt;Sub&gt;1-4&lt;/Sub&gt; alkyl or R, and R&lt;Sub&gt;2&lt;/Sub&gt; together are C&lt;Sub&gt;2&lt;/Sub&gt;- &lt;Sub&gt;5&lt;/Sub&gt;polymethylene;&lt;/ListItem&gt;&lt;ListItem&gt;either R&lt;Sub&gt;3&lt;/Sub&gt; is hydrogen, hydroxy, C&lt;Sub&gt;1-6&lt;/Sub&gt; alkoxy or C&lt;Sub&gt;1-7&lt;/Sub&gt; acyloxy and R4 is hydrogen or R&lt;Sub&gt;3&lt;/Sub&gt; and R&lt;Sub&gt;4&lt;/Sub&gt; together are a bond;&lt;/ListItem&gt;&lt;ListItem&gt;R&lt;Sub&gt;s&lt;/Sub&gt; is hydrogen; C &lt;Sub&gt;1-6&lt;/Sub&gt; alkyl optionally substituted by up to three halo atoms, by hydroxy, C&lt;Sub&gt;1-6&lt;/Sub&gt; alkoxy, C&lt;Sub&gt;1-&lt;/Sub&gt;&lt;Sub&gt;6&lt;/Sub&gt;alkoxycarbonyl, carboxy, or amino optionally substituted by one or two independent C&lt;Sub&gt;1-6&lt;/Sub&gt; alkyl groups or disubstituted by C&lt;Sub&gt;4&lt;/Sub&gt;.&lt;Sub&gt;5&lt;/Sub&gt; polymethylene; C &lt;Sub&gt;2&lt;/Sub&gt;- &lt;Sub&gt;6&lt;/Sub&gt; alkenyl; amino optionally substituted by a C&lt;Sub&gt;1-6&lt;/Sub&gt; alkyl or C&lt;Sub&gt;1-6&lt;/Sub&gt;alkenyl group or by a C&lt;Sub&gt;1-6&lt;/Sub&gt; alkanoyl group optionally substituted by up to three halo atoms, by a phenyl group optionally substituted by C&lt;Sub&gt;1-6&lt;/Sub&gt; alkyl, C&lt;Sub&gt;1-6&lt;/Sub&gt; alkoxy or halogen; or aryl or heteroaryl, either being optionally substituted by one or more groups or atoms selected from the class of C&lt;Sub&gt;1-6&lt;/Sub&gt; alkyl, C&lt;Sub&gt;1-6&lt;/Sub&gt; alkoxy, hydroxy, halogen, trifluoromethyl, nitro, cyano, C&lt;Sub&gt;1-12&lt;/Sub&gt;carboxylic acyl, or amino or aminocarbonyl optionally substituted by one or two C&lt;Sub&gt;1-6&lt;/Sub&gt; alkyl groups; or (when X is 0), R&lt;Sub&gt;s&lt;/Sub&gt; is selected from the class of carboxy, C&lt;Sub&gt;1-&lt;/Sub&gt;&lt;Sub&gt;6&lt;/Sub&gt;alkoxycarbonyl, or aminocarbonyl optionally substituted by one or two C&lt;Sub&gt;1-6&lt;/Sub&gt; alkyl groups; and&lt;/ListItem&gt;&lt;ListItem&gt;R&lt;Sub&gt;6&lt;/Sub&gt; is hydrogen or C&lt;Sub&gt;1-6&lt;/Sub&gt; alkyl; or&lt;/ListItem&gt;&lt;ListItem&gt;R&lt;Sub&gt;s&lt;/Sub&gt; and R&lt;Sub&gt;6&lt;/Sub&gt;together are -CH&lt;Sub&gt;2&lt;/Sub&gt;-(CH&lt;Sub&gt;2&lt;/Sub&gt;) -Z-(CH2)m-wherein m and n are 0 to 2 such that m + n is 1 or 2 and Z is CH&lt;Sub&gt;2&lt;/Sub&gt;, O, S or NR wherein R is hydrogen, C &lt;Sub&gt;1-9&lt;/Sub&gt; alkyl, &lt;Sub&gt;2-7&lt;/Sub&gt;alkanoyl, phenyl C&lt;Sub&gt;1-4&lt;/Sub&gt;-alkyl, naphthylcarbonyl, phenylcarbonyl or benzyl-carbonyl optionally substituted in the phenyl or naphthyl ring by one or two of C&lt;Sub&gt;1-6&lt;/Sub&gt; alkyl, C&lt;Sub&gt;1-6&lt;/Sub&gt; alkoxy or halogen; or R is heteroarylcarbonyl;&lt;/ListItem&gt;&lt;ListItem&gt;or halogen, or aryl or heteroaryl, either being optionally substituted by one or more groups or atoms X is oxygen or sulphur; or&lt;/ListItem&gt;&lt;ListItem&gt;R&lt;Sub&gt;s&lt;/Sub&gt;, R&lt;Sub&gt;6&lt;/Sub&gt;, X and N together are tetrahydroisoquinolinone or tetrahydroisoquinolin- thione optionally substituted in the phenyl ring as defined for R above;&lt;/ListItem&gt;&lt;ListItem&gt;the nitrogen-containing group in the 4-position being trans to the R&lt;Sub&gt;3&lt;/Sub&gt; group when R&lt;Sub&gt;3&lt;/Sub&gt; is hydroxy, C&lt;Sub&gt;1-6&lt;/Sub&gt; alkoxy or C&lt;Sub&gt;1-7&lt;/Sub&gt; acyloxy; having pharmacological activity, including blood pressure lowering activity, a process and intermediates for their preparation and their use as pharmaceuticals.&lt;/ListItem&gt;&lt;/UnorderedLists&gt;</p>
申请公布号 EP0205292(A2) 申请公布日期 1986.12.17
申请号 EP19860304139 申请日期 1986.05.30
申请人 BEECHAM GROUP PLC 发明人 EVANS, JOHN MORRIS;STEMP, GEOFFREY;CASSIDY, FREDERICK
分类号 A61K31/435;A61P9/12;C07D491/04;C07D491/052;C07D491/10;C07D491/107;C07D491/14;C07D491/153;(IPC1-7):C07D491/04 主分类号 A61K31/435
代理机构 代理人
主权项
地址